Vitamin D is part of a complex steroid hormone system long known to be involved in bone metabolism. Recently, vitamin D has been implicated in physiologic processes as diverse as vascular health, immune function, metabolism and placental function. This review summarizes the current evidence for the role of vitamin D in pregnancy and perinatal outcomes A systematic review of articles published in PubMed between May 2010 and October 2011 was undertaken using key words for vitamin D and pregnancy. Seventy-eight studies were reviewed.
INTRODUCTION
Vitamin D deficiency in the form of rickets was first described in the 17th century [1] . The 'vitamin'actually a fat-soluble steroid hormone -was not discovered until the early 20th century. A successful public health campaign, centered on cod liver oil supplementation and fortification of dairy products, was thought to have reduced vitamin D deficiency in developed countries [2] . Recently, the prevalence of rickets has increased and this has resulted in a new interest among scientists in determining the prevalence of vitamin D deficiency and resulting health consequences. Recent biochemical and molecular studies suggest that the effects of vitamin D deficiency could be much broader than rickets including cardiovascular disease, cancers, diabetes and pregnancy complications.
The naturally occurring form of vitamin D in humans is cholecalciferol or vitamin D 3 [3, 4] . It can be ingested in the diet (animal products) or produced in the skin when ultraviolet light interacts with a cholesterol derivative. Vitamin D 2 or ergocalciferol is derived from plant sterols and is the form contained in most vitamin D supplements. Both D 2 and D 3 travel in the blood bound to vitamin D-binding protein and must be hydroxylated to become active. D 3 and D 2 metabolites are thought to have equal physiologic activity, but D 3 levels may increase more quickly after supplementation. Current assays may perform differently when measuring D 2 or D 3 metabolites.
Vitamin D is first hydroxylated in the liver. The resulting metabolite, 25-hydroxy vitamin D, is very stable and is, therefore, most commonly used to measure vitamin D status. The second hydroxylation to the active form 1,25-hydroxy vitamin D occurs mostly in the kidneys in a process tightly regulated by calcium, phosphorus and parathyroid hormone levels [5] . After the second hydroxylation, 1,25-hydroxy vitamin D binds to the vitamin D receptor (VDR). VDR is a transcription factor whose products are involved in a wide array of activities including bone metabolism, cellular growth and differentiation, glucose metabolism and immune function. Both the enzyme responsible for vitamin D activation (1ahydroxyase) and its receptor have been located in peripheral tissues such as the placenta suggesting a farther-reaching role for vitamin D than bone metabolism alone (see Fig. 1 ) [6] .
During pregnancy, serum levels of 1,25-hydroxy vitamin D increase up to two-fold starting at 10-12 weeks of gestation and reaching a maximum in the third trimester [4] . It is unclear whether 25-hydroxy vitamin D levels increase during pregnancy [7 && ]. However, given an increase in the active form of vitamin D, pregnant women likely have a higher cellular exposure to vitamin D during the second and third trimesters suggesting a role for vitamin D in obstetric well being. Perinatal outcomes hypothesized to be related to vitamin D include preeclampsia, gestational diabetes, low birthweight, preterm delivery, cesarean section and infectious disease. This review will summarize scientific literature published in the last 18 months regarding the potential role of vitamin D in improving perinatal outcomes.
METHODS
Medline was searched with key words related to vitamin D and pregnancy. We limited the search to English language articles published between May 1, 2010 and October 31, 2011. Inclusion criteria were human or animal pregnant patients, perinatal outcomes, and in-vitro, animal, case-control, cohort, systematic review or clinical trial study design. Articles reporting on infant, childhood or long-term maternal outcomes associated with maternal vitamin D status were excluded.
The Medline search resulted in 250 citations. After abstract review, 137 were excluded due to lack of pregnant patients, perinatal outcomes or original research. After full-text review, 38 additional articles were excluded that were not original research. The remaining 75 articles were reviewed. The reference sections of the articles were hand searched for additional citations; three such studies were reviewed. Key articles published prior to May 2010 were reviewed in order to provide context.
VITAMIN D PHYSIOLOGY IN PREGNANCY
VDR and 1ahydroxylase are active in reproductive tissues, but their roles in those tissues are still being elucidated. In pregnant mice, VDR was expressed differentially throughout pregnancy in placental, decidual and ovarian follicular tissue supporting the hypothesis that vitamin D is integrally involved in the physiologic changes of pregnancy
] compared gene expression profiles of pregnant women with low levels of vitamin D (<25.5 ng/ml) with those with higher levels (>31.7 ng/ml). Over 300 genes showed significant differences in expression of at least 1.5-fold. Affected genes were known to be involved in a variety of functions such as angiogenesis, carbohydrate metabolism and immune function.
One mechanism whereby vitamin D may affect pregnancy outcomes is modulation of the immune response. 1,25-hydroxy vitamin D and 25(OH)D treatments of human trophoblast cells significantly altered the innate immune response [10, 11] . In VDR or 1ahydroxylase knockout mice, trophoblast cells had an increased inflammatory response to bacterial components compared with wild-type cells [12] . Treatment of wild-type cells with 25-hydroxy vitamin D significantly suppressed the inflammatory response compared with that of untreated cells. In human syncytiotrophoblastic cells, high doses of vitamin D decreased markers of oxidative stress [13] .
IDENTIFYING VITAMIN D DEFICIENCY
Measuring vitamin D deficiency in pregnant women is complicated by a lack of agreement among researchers in three areas: whether 25 considered optimal in pregnant women and which test of vitamin D deficiency is the most accurate. 25-hydroxy vitamin D is the clinical and research gold standard measure of vitamin D status. However, given the complexity of the vitamin D system, it is unclear whether 25-hydroxy vitamin D levels have the same clinical implications in all women or throughout all stages of pregnancy. For example, although 25-hydroxy vitamin D levels were lower among black than white women in one study, their vitamin D-binding protein levels were also lower resulting in equivalent levels of calculated free 1,25-hydroxy vitamin D [14 && ]. Some researchers suggest measuring parathyroid hormone levels as a biologic marker of vitamin D deficiency. However, parathyroid hormone levels have been inconsistently associated with 25-hydroxy vitamin D levels of pregnant women [15-17,18 && ,19]. This may be due to a threshold effect: Parathyroid hormone levels are only increased when 25-hydroxy vitamin D is very low (e.g. 20 ng/l). However, such a threshold has not been identified [19] .
According to 2010 Institute of Medicine (IOM) recommendations, 12 ng/l (30 nmol/l) of 25hydroxy vitamin D is the point below which 'persons are at risk for bone deficiency'. 'Some, but not all are potentially at risk' with levels below 20 ng/l (50 nmol/l) [20 && ]. However, the 2011 American College of Obstetrics and Gynecology (ACOG) Practice Bulletin 'vitamin D: screening and supplementation' defines deficiency as 25-hydroxy vitamin D levels less than 20 ng/l (50 nmol/l) [21 && ]. These cut points and others are used to define vitamin D deficiency in different studies; therefore, levels of 'vitamin D deficiency' in various populations cannot be directly compared.
Finally, there are multiple commercially available 25-hydroxy vitamin D assays, which do not yield identical results. This makes comparing data from multiple studies more complicated [22 & ,23]. Historically 25-hydroxy vitamin D has been measured with protein-binding immunoassays, but liquid chromatography with tandem mass spectroscopy may be the most accurate technology [24] .
VITAMIN D DEFICIENCY AND RISK FACTORS IN PREGNANCY
Using the IOM cut points, 7% of US pregnant or lactating women in a large national database were at risk for vitamin D deficiency (<12 ng/l) and an additional 21% were at risk for inadequacy in 2006 (<20 ng/l) [ 
TREATING VITAMIN D DEFICIENCY IN PREGNANCY
Sun exposure is measured by a variety of methods: latitude, season, skin coverage with clothing, skin pigmentation and ethnicity. However, in all studies, more sun exposure is significantly associated with increased vitamin D levels. Sun exposure may be more strongly associated with vitamin D levels than oral vitamin D intake [22 & ]. There are no trials of sun exposure to increase vitamin D levels in pregnancy.
Vitamin D supplementation likely increases 25-hydroxy vitamin D levels. Supplemented women had less vitamin D deficiency in three large well controlled cohorts (N ¼ 1539), a similar trend in one poorer quality study (N ¼ 201) and no difference in one study with an overall low rate of supplementation (N ¼ 559) [ ]. Randomized controlled trials (RCTs) of vitamin D supplementation have consistently shown success in raising 25-hydroxy vitamin D levels in pregnant women and neonates albeit with varying doses of 25-hydroxy vitamin D [38] . Only one negative trial is reported in the literature, and the dose was 400 IU. All other doses were higher, ranging from 800-1000 IU/day to 100 000-200 000 IU given as onetime doses. Despite increases with supplementation, 25-hydroxy vitamin D levels remained low in most studies. A recent randomized, double-blinded placebo controlled trial occurred in pregnant South Carolina women. The treatment arms were 2000 IU vitamin D daily and standard prenatal vitamins and 4000 IU vitamin D daily and standard prenatal vitamins compared with a placebo arm consisting of a placebo pill and standard prenatal vitamins. The mean vitamin D level measured at 36 weeks was 79 nmol/l for the control group, 105 for the 2000 IU group and 119 for the 4000 IU group. This difference was statistically significant (P < 0.0001); however, the levels were higher than most other trials even in the placebo group. Unfortunately, almost 30% of the participants were excluded from the analysis based on 'poor adherence'. Although the intervention decreased 'vitamin D deficiency', no difference was found in perinatal outcomes measured. In its 2010 recommendations, the IOM recommended 600 IU/day of 25-hydroxy vitamin D for pregnant women specifically to support bone metabolism and no more than 4000 IU/day to avoid hypercalcemia [20 && ]. ACOG endorses these recommendations and proposes 1000-2000 IU/day of 25(OH)D when deficiency is identified (<20 ng/ml) [21 && ]. Dietary intake may be another avenue to increase vitamin D levels. Vitamin D deficiency is not as high as expected in countries at higher latitudes (less sun exposure) such as northern Europe, United States and Canada [39 & ]. This finding may be explained by the higher rates of cod liver oil supplementation and fortified dairy products in these countries. Women with a diet higher in dairy, poultry and eggs had less vitamin D deficiency in Pakistan [26] . US women with lower vitamin D dietary intake had more deficiency [17,27,28 & ]. All data regarding diet are self-reported. There are no clinical trials regarding increasing vitamin D status through dietary modification.
VITAMIN D AND PREGNANCY OUTCOMES
A 2010 systematic review of first trimester 25hydroxy vitamin D levels and adverse pregnancy outcomes concluded that evidence regarding the association between vitamin D levels and pregnancy complications such as preeclampsia and diabetes is inconclusive, but warrants further investigation [40 && ]. The five studies reviewed were nested casecontrol studies and only a minority controlled for dietary quality or intake of vitamin D. This is perplexing and could result in confounding; dietary quality is likely associated with adverse pregnancy outcomes as well as vitamin D deficiency. Recent observational studies investigating the associations between 25-hydroxy vitamin D levels in pregnant women and perinatal outcomes are summarized below. The only recent randomized trial of vitamin D supplementation found no change in birthweight, gestational age at delivery or cesarean delivery among supplemented women despite increased circulating levels of 25-hydroxy vitamin D. Recent studies investigating the association between vitamin D levels and specific pregnancy complications will now be reviewed.
Gestational hypertension/preeclampsia
Vitamin D and its receptor are active in the human placenta and immune modulation suggesting a causative role for vitamin D deficiency and preeclampsia. This hypothesis has been supported by a cohort study of women exposed and unexposed to vitamin D supplementation, one RCT of vitamin D supplements, and one RCT of fish oil supplements [41] [42] [43] . Women exposed to vitamin D developed less preeclampsia. A 2011 systematic review found that hypertension in pregnancy is more common in winter or rainy seasons when vitamin D deficiency is also higher [44] . Higher vitamin D levels have been consistently associated with lower preeclampsia incidence and lower blood pressure when measured at diagnosis or delivery [45] [46] [47] . However, it is unclear which comes first. Therefore, several groups have sought to determine whether 25-hydroxy vitamin D levels measured prior to the diagnosis of preeclampsia are associated with the diagnosis [14 && , [48] [49] [50] [51] [52] . The findings of these mostly casecontrol studies are mixed. The two cohort studies found no association. There are likely several reasons for this inconsistency: small sample sizes leading to insufficient power, different control groups (some studies excluded 'complicated pregnancies'), racial/ethnic and socioeconomic heterogeneity of populations studied, different methods of measuring 25-hydroxy vitamin D concentration, different cut points for vitamin D deficiency and incomplete adjustment for confounding by vitamin D dietary intake and sun exposure. Overall, the findings suggest that 25-hydroxy vitamin D levels in early pregnancy may be associated with later preeclampsia only in specific subgroups: women with very low levels of 25-hydroxy vitamin D (<13.2 ng/l) or African-American women.
Gestational diabetes
In nonpregnant adults, vitamin D deficiency has been associated with higher levels of type 2 diabetes. Studies investigating the relationship between vitamin D levels and gestational diabetes (GDM) have mixed results. Three recent case-control studies from India, the United Kingdom and North Carolina aimed to determine whether early pregnancy 25-hydroxy vitamin D levels were associated with a later diagnosis of GDM [53] [54] [55] . Results were mixed. In one, women with GDM had 2.7 times the odds [confidence interval (CI) 1-7] of vitamin D deficiency in the first trimester as those without. A second showed no association between low vitamin D levels and a GDM diagnosis but did find increased fasting glucose and hemoglobin A1c at 28 weeks. The third found no association between diagnosis of GDM and first trimester vitamin D deficiency but had very wide CIs. None of the studies were adjusted for dietary factors or sun exposure.
Birthweight
Vitamin D is known to be involved in bone metabolism, therefore, vitamin D deficiency has been hypothesized to be associated with low birthweight. Study results have been mixed both for the association between low birthweight and vitamin D status at delivery and between low birthweight and first trimester 25-hydroxy vitamin D levels [28 & ,56-59] . The largest cohort study (3730 Amsterdam women) found the odds of birthing a baby small for gestational age was higher among women with severe vitamin D deficiency in early pregnancy (<12 ng/l) [60 && ]. None of the studies adjusted their analysis for differences in sun exposure and dietary vitamin D intake among participants which are potential confounders of the results. Taken together, these data suggest that if an association between vitamin D status and infant birthweight exists, it may vary according to subgroups such as severe vitamin D deficiency or race. A potential mechanism for the latter was suggested by Swamy et al. [61 & ]. In a study of VDR haplotypes among a cohort of 615 pregnant women, eight polymorphisms in black women were significantly associated with infant birthweight, and no polymorphisms in white women were associated with birthweight.
Preterm delivery
Given the known association between vitamin D deficiency and increased markers of inflammation, some have suggested a role for vitamin D in prevention of preterm birth. Only a handful of studies have investigated this question. In a recent North Carolina study, 40 cases who suffered a preterm birth without evidence of chorioamnionitis were matched by age and race with three controls [36] . No association between first trimester 25-hydroxy vitamin D deficiency (<50 nmol/l) and spontaneous preterm birth was found. The power was low given low incidence of preterm birth and vitamin D deficiency in this upper class population. A Japanese retrospective study found lower mean 25-hydroxy vitamin D among women in the third trimester that had been hospitalized for preterm labor earlier in the pregnancy. All participants eventually delivered at term [37] .
Cesarean delivery
Severe vitamin D deficiency and rickets causes pelvic deformities, which have been known for many years to increase the risk of obstructed labor. In 2009, a Boston study of 300 women found women with vitamin D levels less than 37.5 ng/l had four times the odds of a cesarean delivery than those with higher levels [62] . A northern California study found no change in mean vitamin D levels between women who underwent cesarean delivery and those who did not after adjustment for confounders [28 & ]. Neither study was adjusted for dietary factors, although the California study adjusted for sun exposure. The RCT of vitamin D supplementation in South Carolina found no difference in cesarean section rates between treatment and control groups [18 && ]. Most likely, only severe cases of vitamin D leading to rickets in childhood increase the risk for cesarean delivery.
Infectious diseases
Vitamin D is involved in immune function. Several groups have investigated associations between vitamin D levels and infectious diseases during pregnancy. In a North Carolina case-control study (cases ¼ 117 controls ¼ 118), women less than 26 weeks of gestation with periodontal disease had two times the odds of vitamin D deficiency. In a US national cohort study (N ¼ 3523), there was no association between bacterial vaginosis and vitamin D status in nonpregnant women; however, in pregnant women, vitamin D deficiency (<30 ng/l) was independently associated with bacterial vaginosis (odds ratio 2.9, CI 1.1-7.3) [63] . HIV mortality, disease progression and anemia were associated with vitamin D deficiency (<32 ng/l) in a cohort of HIVpositive Tanzanian pregnant women [64] . None of the studies adjusted for dietary factors or sun exposure. Additional reasearch is needed to determine if low vitamin D levels increase the risk of infectious disease during pregnancy.
CONCLUSION
Biologic data suggest a role for vitamin D in women's reproductive health. However, results from studies investigating the link between 25-hydroxy vitamin D levels and adverse pregnancy outcomes are contradictory. This is likely due to small sample sizes, inadequate control for confounding, significant heterogeneity in populations studied and significant heterogeneity in exposure measurement [41] . A standard definition of vitamin D deficiency in pregnancy must be determined. A pooled analysis of observational studies could then be considered. Vitamin D is likely involved in reproductive health; however, it is unlikely to be the cure for pregnancy complications that have multifactorial causes. Until we have clear evidence for optimal levels during pregnancy, IOM guidelines recommending 600 IU of daily vitamin D supplementation for pregnant women should be followed.
